WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 7, 2005, 25(36):8240-8249; doi:10.1523/JNEUROSCI.1808-05.2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (42)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koenigsknecht-Talboo, J.
Right arrow Articles by Landreth, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koenigsknecht-Talboo, J.
Right arrow Articles by Landreth, G. E.

 Previous Article  |  Next Article 

Neurobiology of Disease
Microglial Phagocytosis Induced by Fibrillar {beta}-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines

Jessica Koenigsknecht-Talboo and Gary E. Landreth

Alzheimer Research Laboratory, Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106

Microglia undergo a phenotypic activation in response to fibrillar {beta}-amyloid (fA{beta}) deposition in the brains of Alzheimer's disease (AD) patients, resulting in their elaboration of inflammatory molecules. Despite the presence of abundant plaque-associated microglia in the brains of AD patients and in animal models of the disease, microglia fail to efficiently clear fA{beta} deposits. However, they can be induced to do so during A{beta} vaccination therapy attributable to anti-A{beta} antibody stimulation of IgG receptor (FcR)-mediated phagocytic clearance of A{beta} plaques.

We report that proinflammatory cytokines attenuate microglial phagocytosis stimulated by fA{beta} or complement receptor 3 and argue that this may, in part, underlie the accumulation of fA{beta}-containing plaques within the AD brain. The proinflammatory suppression of fA{beta}-elicited phagocytosis is dependent on nuclear factor {kappa}B activation. Significantly, the proinflammatory cytokines do not inhibit phagocytosis elicited by antibody-mediated activation of FcR, which may contribute to the efficiency of A{beta} vaccination-based therapy. Importantly, the proinflammatory suppression of fA{beta} phagocytosis can be relieved by the coincubation with anti-inflammatory cytokines, cyclooxygenase inhibitors, ibuprofen, or an E prostanoid receptor antagonist, suggesting that proinflammatory cytokines induce the production of prostaglandins, leading to an E prostanoid receptor-dependent inhibition of phagocytosis. These findings support anti-inflammatory therapies for the treatment of AD.

Key words: phagocytosis; {beta}-amyloid; Alzheimer's disease; NSAIDs; inflammation; cytokines


Received May 5, 2005; revised July 21, 2005; accepted July 21, 2005.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. Jimenez, D. Baglietto-Vargas, C. Caballero, I. Moreno-Gonzalez, M. Torres, R. Sanchez-Varo, D. Ruano, M. Vizuete, A. Gutierrez, and J. Vitorica
Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic
J. Neurosci., November 5, 2008; 28(45): 11650 - 11661.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Shimizu, K. Kawahara, M. Kajizono, M. Sawada, and H. Nakayama
IL-4-Induced Selective Clearance of Oligomeric {beta}-Amyloid Peptide1-42 by Rat Primary Type 2 Microglia
J. Immunol., November 1, 2008; 181(9): 6503 - 6513.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Maier, Y. Peng, L. Jiang, T. J. Seabrook, M. C. Carroll, and C. A. Lemere
Complement C3 Deficiency Leads to Accelerated Amyloid {beta} Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice
J. Neurosci., June 18, 2008; 28(25): 6333 - 6341.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Zelcer, N. Khanlou, R. Clare, Q. Jiang, E. G. Reed-Geaghan, G. E. Landreth, H. V. Vinters, and P. Tontonoz
Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors
PNAS, June 19, 2007; 104(25): 10601 - 10606.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Yamamoto, T. Kiyota, M. Horiba, J. L. Buescher, S. M. Walsh, H. E. Gendelman, and T. Ikezu
Interferon-{gamma} and Tumor Necrosis Factor-{alpha} Regulate Amyloid-{beta} Plaque Deposition and {beta}-Secretase Expression in Swedish Mutant APP Transgenic Mice
Am. J. Pathol., February 1, 2007; 170(2): 680 - 692.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Wilkinson, J. Koenigsknecht-Talboo, C. Grommes, C. Y. D. Lee, and G. Landreth
Fibrillar beta-Amyloid-stimulated Intracellular Signaling Cascades Require Vav for Induction of Respiratory Burst and Phagocytosis in Monocytes and Microglia
J. Biol. Chem., July 28, 2006; 281(30): 20842 - 20850.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. G. Walker, J. Link, L.-F. Lue, J. E. Dalsing-Hernandez, and B. E. Boyes
Gene expression changes by amyloid {beta} peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes
J. Leukoc. Biol., March 1, 2006; 79(3): 596 - 610.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-